Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Investigative Dermatology

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jid.2010.326PMID 21068757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.

  2010cited by this paper
• Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen

  2009cited by this paper
• AXL is a potential target for therapeutic intervention in breast cancer progression.

  2008cited by this paper
• Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.

  2008cited by this paper
• Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.

  2007cited by this paper
• The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest.

  2007cited by this paper
• Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway

  2007cited by this paper
• Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies

  2006cited by this paper
• Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

  2006cited by this paper
• Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.

  2006cited by this paper
• Caspase-dependent and -independent pathways for cadmium-induced apoptosis in cultured kidney proximal tubule cells.

  2006cited by this paper
• Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours

  2006cited by this paper
• Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor

  2005cited by this paper
• Role of apoptosis in basal cell and squamous cell carcinoma formation.

  2005cited by this paper
• The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin.

  2005cited by this paper
• AKT status controls susceptibility of malignant keratinocytes to the early-activated and UVB-induced apoptotic pathway.

  2004cited by this paper
• Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.

  2003cited by this paper
• Bcl-2-family proteins and the role of mitochondria in apoptosis.

  2003cited by this paper
• Expression profile of tyrosine kinases in breast cancer.

  2002cited by this paper
• Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus

  2002cited by this paper
• The epidemiology of skin cancer

  2002cited by this paper
• Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.

  2002cited by this paper
• Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

  2002cited by this paper
• Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis

  2002cited by this paper
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

  2001influential reference
• Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein Complex*

  2001cited by this paper
• Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

  2000cited by this paper
• Phosphorylation of the PTEN Tail Regulates Protein Stability and Function

  2000cited by this paper
• Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release

  2000cited by this paper
• Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis

  2000cited by this paper
• Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras

  1999cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

  1996cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Chapter 15 Serial Cultivation of Normal Human Epidermal Keratinocytes

  1980cited by this paper
• Serial cultivation of normal human epidermal keratinocytes.

  1980cited by this paper

• Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications

  2024cites this paper
• Revolutionizing non‐melanoma skin cancer treatment: Receptor tyrosine kinase inhibitors take the stage

  2024cites this paper
• TAM family kinases as therapeutic targets at the interface of cancer and immunity

  2023influential citation
• Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma

  2023cites this paper
• Inhibition of a new AXL isoform (AXL3) induces apoptosis of mantle cell lymphoma cells.

  2023cites this paper
• Phosphoproteomic analysis of the AKT signalling axis in cutaneous squamous carcinoma progression reveals novel therapeutic targets

  2022cites this paper
• Distinctive Expression of DNA Replication Factors in Squamous Cell Carcinomas of the Lip, Face and Oral Cavity.

  2022cites this paper
• TAM kinases as regulators of cell death.

  2021cites this paper
• The Hypoxia–Long Noncoding RNA Interaction in Solid Cancers

  2021cites this paper
• Post-translational modifications of the ligands: Requirement for TAM receptor activation.

  2020cites this paper
• The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties.

  2020cites this paper
• The up-regulation of Axl is associated with a poor prognosis and promotes proliferation in pancreatic ductal adenocarcinoma.

  2019cites this paper
• A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing

  2019cites this paper
• Roles for AXL and MERTK in Resistance to Cytotoxic and Targeted Therapies

  2019cites this paper
• Axl inhibitors as novel cancer therapeutic agents.

  2018cites this paper
• Investigations of the cancer therapeutic and protective effects of warfarin-mediated inhibition of the receptor tyrosine kinase AXL

  2017cites this paper
• The Role of Axl Receptor Tyrosine Kinase in Tumor Cell Plasticity and Therapy Resistance

  2017cites this paper
• Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas

  2017cites this paper
• High BIM mRNA levels are associated with longer survival in advanced gastric cancer.

  2017cites this paper
• Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor

  2017cites this paper
• Function of Axl receptor tyrosine kinase in non-small cell lung cancer.

  2017cites this paper
• TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.

  2017cites this paper
• 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors.

  2016cites this paper
• Gas6/Axl Inhibits Osteosarcoma Apoptosis through Regulation of Apoptosis-Related Protein Bcl-2

  2016cites this paper
• The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma

  2014cites this paper
• Axl as a mediator of cellular growth and survival

  2014cites this paper
• AXL kinase as a novel target for cancer therapy

  2014cites this paper
• The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

  2014cites this paper
• Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients.

  2013cites this paper
• A miR‐34a‐SIRT6 axis in the squamous cell differentiation network

  2013cites this paper
• Tyrosine Kinase Inhibitors in Thyroid Cancer: May Axl/Gas6 Pathway be a Hidden Target?

  2013cites this paper
• Identifying the role of Mer receptor tyrosine kinase in glioblastoma multiforme

  2012cites this paper
• Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands

  2011cites this paper
• THE ROLE OF RECEPTOR TYROSINE KINASE AXL IN PANCREATIC DUCTAL ADENOCARCINOMA AND ITS REGULATION BY HEMATOPOIETIC PROGENITOR KINASE 1

  2011cites this paper